Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

Purpose. The addition of cetuximab to radiochemotherapy (RCT) failed to improve complete response rates in locally advanced rectal cancer (LARC). We report the long-term results in patients treated within two sequential clinical trials. Methods. Patients receiving neoadjuvant RCT using capecitabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kripp, M., Horisberger, K., Mai, S., Kienle, P., Gaiser, T., Post, S., Wenz, F., Merx, K., Hofheinz, R.-D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377474/
https://www.ncbi.nlm.nih.gov/pubmed/25861256
http://dx.doi.org/10.1155/2015/273489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377474/
https://www.ncbi.nlm.nih.gov/pubmed/25861256
http://dx.doi.org/10.1155/2015/273489

Ejemplares similares